Our vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). The investment was made in partnership with sofie's founding team, who will retain a We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics).
Are you passionate about healthcare and improving the lives of patients We have taken bold steps to advance the development of next generation theranostic agents through scientific collaborations. Join our team to make a difference.
Our product lines include fdg, pylarify, neuraceq, and other clinical trial products. Our team works alongside our pharma and academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease.
